-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OX50wbNS9ywEKpRWU0V4UYbZ08Y9U4roff1mxhEMrlcMTvY605iC8t/zojkjxkbr 3Y6w9Jlqio2fMBvtDhHOOA== 0001299933-06-004299.txt : 20060621 0001299933-06-004299.hdr.sgml : 20060621 20060621143031 ACCESSION NUMBER: 0001299933-06-004299 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20060620 ITEM INFORMATION: Entry into a Material Definitive Agreement FILED AS OF DATE: 20060621 DATE AS OF CHANGE: 20060621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ROCHESTER MEDICAL CORPORATION CENTRAL INDEX KEY: 0000868368 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 411613227 STATE OF INCORPORATION: MN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 000-18933 FILM NUMBER: 06917159 BUSINESS ADDRESS: STREET 1: ONE ROCHESTER MEDICAL DR CITY: STEWARTVILLE STATE: MN ZIP: 55976 BUSINESS PHONE: 5075339600 MAIL ADDRESS: STREET 1: ONE ROCHESTER MEDICAL DR CITY: STEWARTVILLE STATE: MN ZIP: 55976 8-K 1 htm_13296.htm LIVE FILING Rochester Medical Corporation (Form: 8-K)  

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

     
Date of Report (Date of Earliest Event Reported):   June 20, 2006

Rochester Medical Corporation
__________________________________________
(Exact name of registrant as specified in its charter)

     
Minnesota 0-18933 41-1613227
_____________________
(State or other jurisdiction 		_____________
(Commission 		______________
(I.R.S. Employer
of incorporation) File Number) Identification No.)
      
One Rochester Medical Drive, Stewartville, Minnesota   55976
_________________________________
(Address of principal executive offices) 		  ___________
(Zip Code)
     
Registrant’s telephone number, including area code:   507-533-9600

Not Applicable
______________________________________________
Former name or former address, if changed since last report

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[  ]  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[  ]  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[  ]  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[  ]  Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01 Entry into a Material Definitive Agreement.

On June 20, 2006, the Compensation Committee of the Board of Directors of Rochester Medical Corporation (the "registrant") awarded special cash bonuses in the amount of $20,000 to each of David A. Jonas, Chief Financial Officer, and Martyn R. Sholtis, Corporate Vice President, in connection with the successful closing of the transactions with Coloplast A/S ("Coloplast"), Coloplast Limited (a subsidiary of Coloplast), Mentor Corporation and Mentor Medical Limited (a subsidiary of Mentor) and the formation of Rochester Medical Limited, a subsidiary of the registrant established to operate the registrant’s Male External Catheters business in the United Kingdom. Each of these officers had significant involvement in, and devoted a significant amount of time to, the transactions, which closed on June 2, 2006.





SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

         
    Rochester Medical Corporation
          
June 21, 2006   By:   David A. Jonas
       
        Name: David A. Jonas
        Title: Chief Financial Officer
-----END PRIVACY-ENHANCED MESSAGE-----